Robert Hershberg insider trades
Open-market stock purchases and sales by Robert Hershberg, Director at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 2, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold | $125K |
| Oct 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | $55.5K |
| Sep 11, 2026 | ATAI AtaiBeckley Inc | Sold (not open market) | $66K |
| Sep 11, 2026 | ATAI AtaiBeckley Inc | Sold (not open market) | $547K |
| Sep 11, 2026 | ATAI AtaiBeckley Inc | Sold (not open market) | $84.2K |
| Sep 11, 2026 | ATAI AtaiBeckley Inc | Sold (not open market) | $461K |
| Sep 11, 2026 | ATAI AtaiBeckley Inc | Sold (not open market) | $549K |
| Aug 18, 2026 | ADPT Adaptive Biotechnologies Corp | Sold | $366K |
| Aug 18, 2026 | ADPT Adaptive Biotechnologies Corp | Sold | $382K |
| Aug 18, 2026 | ADPT Adaptive Biotechnologies Corp | Bought (not open market) | — |
| Jul 7, 2026 | ATAI AtaiBeckley Inc | Sold | $496K |
| Jul 7, 2026 | ATAI AtaiBeckley Inc | Bought (not open market) | $66K |
| Jul 7, 2026 | ATAI AtaiBeckley Inc | Bought (not open market) | $69K |
| Jul 7, 2026 | ATAI AtaiBeckley Inc | Bought (not open market) | — |
| Jul 7, 2026 | ATAI AtaiBeckley Inc | Bought (not open market) | — |
| Jun 17, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 4, 2026 | ATAI AtaiBeckley Inc | Bought (not open market) | — |
| Mar 4, 2026 | ADPT Adaptive Biotechnologies Corp | Bought (not open market) | — |
| Dec 10, 2025 | ADPT Adaptive Biotechnologies Corp | Sold | $367K |
| Nov 5, 2025 | ATAI Atai Beckley NV | Bought (not open market) | — |
| Nov 5, 2025 | ATAI Atai Beckley NV | Bought (not open market) | — |
| Nov 5, 2025 | ATAI Atai Beckley NV | Bought (not open market) | — |
| Nov 5, 2025 | ATAI Atai Beckley NV | Bought (not open market) | — |
Companies traded
- RXRX Recursion Pharmaceuticals, Inc: 1 sale, last Oct 6, 2026
- ATAI AtaiBeckley Inc: 1 sale, last Sep 11, 2026
- ADPT Adaptive Biotechnologies Corp: 25 sales, last Aug 18, 2026
- HLVX HilleVax, Inc: 3 sales, last Sep 17, 2025
- FATE Fate Therapeutics Inc: 1 sale, last Jun 6, 2023
- SBTX Silverback Therapeutics, Inc: other filings, last Jun 10, 2022
- NSTG NanoString Technologies Inc: 32 sales, last Apr 18, 2022